CC

Casdin Capital Portfolio holdings

AUM $1.1B
1-Year Est. Return 24.98%
This Quarter Est. Return
1 Year Est. Return
+24.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.1B
AUM Growth
-$126M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$10.9M
2
+$7.96M
3
+$6.63M
4
ILMN icon
Illumina
ILMN
+$4.77M
5
PRME icon
Prime Medicine
PRME
+$2.96M

Top Sells

1
+$29.8M
2
+$28.9M
3
+$21.5M
4
EXAS icon
Exact Sciences
EXAS
+$16.7M
5
NTLA icon
Intellia Therapeutics
NTLA
+$14.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABSI icon
26
Absci
ABSI
$640M
$2.5M 0.23%
973,260
PACB icon
27
Pacific Biosciences
PACB
$703M
$897K 0.08%
723,767
RXRX icon
28
Recursion Pharmaceuticals
RXRX
$2.41B
$837K 0.08%
165,323
IPSC icon
29
Century Therapeutics
IPSC
$50.4M
$686K 0.06%
1,228,190
-1,984,126
CTNM
30
Contineum Therapeutics
CTNM
$321M
$589K 0.05%
148,333
DNA icon
31
Ginkgo Bioworks
DNA
$769M
$411K 0.04%
36,493
GLUE icon
32
Monte Rosa Therapeutics
GLUE
$794M
$388K 0.04%
86,014
TNYA icon
33
Tenaya Therapeutics
TNYA
$235M
$221K 0.02%
361,969
-6,371,002
DYN icon
34
Dyne Therapeutics
DYN
$3.21B
– –
-100,000
GEHC icon
35
GE HealthCare
GEHC
$34.1B
– –
-100,000
BPMC
36
DELISTED
Blueprint Medicines
BPMC
– –
-326,378
KRON
37
DELISTED
Kronos Bio
KRON
– –
-123,839
MRNA icon
38
Moderna
MRNA
$10.6B
– –
-225,000
NTLA icon
39
Intellia Therapeutics
NTLA
$1.35B
– –
-2,000,000
SLDB icon
40
Solid Biosciences
SLDB
$420M
– –
-775,000
TDOC icon
41
Teladoc Health
TDOC
$1.53B
– –
-300,000
TNGX icon
42
Tango Therapeutics
TNGX
$1.07B
– –
-125,000
TSVT
43
DELISTED
2seventy bio
TSVT
– –
-2,000,000
VSTM icon
44
Verastem
VSTM
$582M
– –
-600,000
ONC
45
BeOne Medicines Ltd
ONC
$34.1B
– –
-40,000
1
2